نتائج البحث 291-300 من 8217 لعملية البحث عن Lymphoma red flag
... lymphoma. Ibrutinib may stop the growth of cancer cells by blocking some of ... A Study to Evaluate Acalabrutinib With or Without Obinutuzumab to Treat Early- ...
Freedman A, et al. Clinical manifestations, pathologic features, and diagnosis of peripheral T-cell lymphoma, not otherwise specified. https://www.uptodate.com/ ...
The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.
Blood Cancers & Disorders Discussions. roberthall0452. Anyone else have Mantle Cell Lymphoma? 116 Replies Sun, Jul 26, 2026.
The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has ...
David J. DiCaudo, M.D.. Pathologist; Dermatologist; Dermatopathologist. Phoenix, AZ. مناطق التركيز: Cutaneous t-cell lymphoma, Sezary syndrome, T ...
This trial may help find out if this approach is better or worse than the usual approach for treating peripheral T-cell lymphoma. Trimethoprim-sulfamethoxazole ...
Blood Cancers & Disorders Discussions. roberthall0452. Anyone else have Mantle Cell Lymphoma? 119 Replies Wed, Sep 02, 2026.
Thomas E. Witzig, M.D.. Internist; Oncologist; Hematologist. Rochester, MN. مناطق التركيز: Multiple myeloma, Non-Hodgkin lymphoma, Hodgkin ...
This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or does ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.